Nuwellis NUWE
NASDAQ NUWE
$0.80 +0.01 (+1.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026)

Nuwellis' (NUWE) quarterly Liabilities and Shareholders Equity came in at $9.1 million in Q2 2026, down 0.8% on a YoY basis from $9.2 million in Q2 2025, and up 31.1% quarter-over-quarter from $7.0 million in Q1 2026.

Analysis

Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Nuwellis (NUWE) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $9.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 0.8% year-over-year to $9.1 million; the trailing twelve-month figure through Jun 2026 stood at $30.2 million (down 7.95% YoY), and the FY2025 full-year result was $6.1 million, down 37.98% from the prior year.
  • Liabilities and Shareholders Equity rose to $9.1 million in Q2 2026 per NUWE's latest filing, from $7.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $26.1 million in Q1 2022 and bottomed at $6.1 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $12.3 million across 5 years, with a median of $9.5 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity slumped 63.95% in 2024, then jumped 48.65% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $24.7 million in 2022, then slumped by 60.4% to $9.8 million in 2023, then gained by 0.96% to $9.9 million in 2024, then tumbled by 37.98% to $6.1 million in 2025, then soared by 49.17% to $9.1 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $9.1 million, $7.0 million, and $6.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 93.31 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 13.87 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 6.46 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 10.74 Bn
10 Nuwellis 140,408.95 -3.78 Mn 1.50 Mn 9.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.13 Mn
Mar 31, 2026 6.96 Mn
Dec 31, 2025 6.12 Mn
Sep 30, 2025 7.98 Mn
Jun 30, 2025 9.20 Mn
Mar 31, 2025 7.01 Mn
Dec 31, 2024 9.86 Mn
Sep 30, 2024 6.73 Mn
Jun 30, 2024 6.19 Mn
Mar 31, 2024 6.66 Mn
Dec 31, 2023 9.77 Mn
Sep 30, 2023 11.43 Mn
Jun 30, 2023 15.55 Mn
Mar 31, 2023 18.48 Mn
Dec 31, 2022 24.67 Mn
Sep 30, 2022 18.44 Mn
Jun 30, 2022 22.00 Mn
Mar 31, 2022 26.11 Mn
Dec 31, 2021 30.42 Mn
Sep 30, 2021 34.10 Mn